APUS · Apimeds Pharmaceuticals US, Inc.
$5.65
+5.00 (+764.84%)
At close · Jul 24
Going-concern doubt
— flagged May 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not contain any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed May 26, 2026
Market Cap
$85.27M
Shares
15.09M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.